tiprankstipranks
Trending News
More News >

Promino Nutritional Sciences Targets Cancer Therapy Support

Story Highlights
Promino Nutritional Sciences Targets Cancer Therapy Support

Element Nutritional Sciences Inc (TSE:MUSL) has released an update.

Confident Investing Starts Here:

Promino Nutritional Sciences Inc. has initiated a preclinical trial led by Dr. Patrick Gunning to test the effectiveness of its Promino™ product in preserving muscle mass for cancer patients during intense chemotherapy. If successful, the company plans to develop a specialized version for the North American healthcare market. Additionally, Promino has recently achieved milestones in retail partnerships, production, and clinical results, underscoring its growing presence in the nutritional supplement industry.

For further insights into TSE:MUSL stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App